Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersAug 8, 2016View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerJul 26, 2016Download DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECJul 8, 2016View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerJun 24, 2016Download DOCDownload PDF
CT ORDERConfidential treatment orderApr 18, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 16, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 16, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2016View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2016View HTMLDownload DOCDownload PDF

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information